Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 6/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30963680 | 0.83 | KDM4E (0.54) | ALDH1A1PKMKDM4EGAALMNA | |
| SCHEMBL13082241 | 0.78 | ALDH1A1 (0.60) | ALDH1A1PKMKDM4EGAALMNA | |
| SCHEMBL1239654 | 0.76 | IDO1 (0.53) | ALDH1A1GAALMNAKMT2AMEN1 | |
| SCHEMBL11826455 | 0.75 | ALDH1A1 (0.56) | ALDH1A1PKMKDM4EGAALMNA | |
| SCHEMBL20816327 | 0.75 | ALDH1A1 (0.61) | ALDH1A1PKMKDM4EGAALMNA | |
| SCHEMBL18036128 | 0.75 | NPC1 (0.50) | ALDH1A1PKMKDM4EGAALMNA | |
| SCHEMBL11831650 | 0.75 | ALDH1A1 (0.56) | ALDH1A1PKMKDM4EGAALMNA | |
| SCHEMBL20816319 | 0.75 | ALDH1A1 (0.56) | ALDH1A1PKMKDM4EGAALMNA | |
| SCHEMBL30758084 | 0.75 | ALDH1A1 (0.61) | ALDH1A1PKMKDM4EGAALMNA | |
| SCHEMBL22636760 | 0.72 | ALDH1A1 (0.44) | ALDH1A1PKMKDM4EGAALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119874712-A | Pyrrolo-quinoxaline-triphenylamine electroactive material and synthesis and application thereof | 陕西理工大学 | 2025-04-25 | — | — | CN | disclosed |
| CN-119504773-A | Pyrrolo-quinoxaline fused aza-saccharide derivative, synthetic method and application | 河北大学 | 2025-02-25 | — | — | CN | disclosed |
| CN-117551121-A | 4, 5-dihydropyrroloquinoxaline carborane derivative, and preparation method and application thereof | 郑州原理生物科技有限公司 | 2024-02-13 | — | — | CN | disclosed |
| US-7563793-B2 | Pyrrolo[1,2-a]quinoxalin-5-(4H)-yl)sulfonyls and carbonyls and their use as estrogenic agents | WYETH (US) | 2009-07-21 | — | — | US | disclosed |
| US-20060160815-A1 | Pyrrolo[1,2-a]quinoxalin-5-(4H)-yl)sulfonyls and carbonyls and their use as estrogenic agents | WYETH (US) | 2006-07-20 | — | — | US | disclosed |
| WO-2006068928-A1 | PYRROLO[1,2-A]QUINOXALIN-5-(4H)-YL)SULFONYLS AND CARBONYLS AND THEIR USE AS ESTROGENIC AGENTS | WYETH (US) | 2006-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060160815-A1 | Pyrrolo[1,2-a]quinoxalin-5-(4H)-yl)sulfonyls and carbonyls and their use as estrogenic agents | ESR1, GPER1, ESR2 | ALDH1A1 2755/4885PKM 1830/4885KDM4E 90/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.